Rare Diseases: Only 10% of India’s 1.37 Billion People Have Health Insurance

In about five years India’s population will exceed that of China which is currently ranked number one according to population. Contrast these numbers with the fact that only ten percent…

Continue Reading Rare Diseases: Only 10% of India’s 1.37 Billion People Have Health Insurance

The Struggles of being a Rare Disease Patient in China

The State of Rare Diseases in China The Illness Challenge Foundation (ICF) is an organization devoted to easing the burdens that rare disease patients living in China face. They accomplish this…

Continue Reading The Struggles of being a Rare Disease Patient in China

Rare Diseases Could Be Diagnosed Earlier with Better Training for GPs to Avoid Years of Misdiagnosis

Although each disease on its own may be rare, a huge number of people are living with a rare disease-- and half of these people are children. About 30 percent of these children…

Continue Reading Rare Diseases Could Be Diagnosed Earlier with Better Training for GPs to Avoid Years of Misdiagnosis
Amicus Therapeutics and the FDA Have Met to Discuss the Path for a Potential Pompe Disease Therapy
889520 / Pixabay

Amicus Therapeutics and the FDA Have Met to Discuss the Path for a Potential Pompe Disease Therapy

  Amicus Therapeutics has met with the United States Food and Drug Administration to discuss the investigational drug AT-GAA, which is being researched as a potential treatment for Pompe disease.…

Continue Reading Amicus Therapeutics and the FDA Have Met to Discuss the Path for a Potential Pompe Disease Therapy

This Dad Climbed a Literal Mountain for His Daughter with Pompe Disease

The Malaysia Lysosomal Diseases Association (MLDA) was formed in 2011 by the hands of eight families. Their goal was to raise awareness and funds for those diagnosed with lysosomal storage…

Continue Reading This Dad Climbed a Literal Mountain for His Daughter with Pompe Disease
The Developers of an Experimental Pompe Treatment Have Received Advice From Regulatory Authorities
Capri23auto / Pixabay

The Developers of an Experimental Pompe Treatment Have Received Advice From Regulatory Authorities

Amicus Therapeutics is developing a treatment for Pompe disease through its AT-GAA program. They have recently announced that they have met with regulators from the European Union and Germany who…

Continue Reading The Developers of an Experimental Pompe Treatment Have Received Advice From Regulatory Authorities
North Carolina Has Added Three More Conditions to Their Newborn Screening Program
Source: Pixabay

North Carolina Has Added Three More Conditions to Their Newborn Screening Program

Lawmakers in the U.S. state of North Carolina have expanded the state’s newborn screening testing to include three more conditions. These are Pompe disease, Mucopolysaccharidosis type 1 (MPS 1), and…

Continue Reading North Carolina Has Added Three More Conditions to Their Newborn Screening Program
Report: Pharma Can Resume Testing Drug Efficacy for Neurological and Respiratory Conditions
Source: Pixabay

Report: Pharma Can Resume Testing Drug Efficacy for Neurological and Respiratory Conditions

RespireRx Pharmaceuticals announced last month it was cleared to resume its ampakine CX717 clinical trials to evaluate the drug’s efficacy in several central nervous system and respiratory disorders, including Pompe…

Continue Reading Report: Pharma Can Resume Testing Drug Efficacy for Neurological and Respiratory Conditions